Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices.

The risk-factor threshold for considering a patient with hypertrophic cardiomyopathy for a primary-prevention implantable defibrillator can be lower than sometimes occurs in practice, according to ...

Thus, the authors concluded that the ESC hypertrophic cardiomyopathy-sudden cardiac death model provides accurate prognostic information which can be used to target ICD therapy in patients at the ...

Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2023.Readers were most interested in the FDA approval of a extravascular ICD system with anti ...

However, accurately selecting which HCM patients need this ICD device, which is implanted in the patient for their lifetime, has been challenging, and which methods to use have been debatable.

Patients with HCM phenocopies or an ICD were excluded. Participants underwent extended ECG monitoring for 30 days using a dedicated device.

A large study conducted across North America, Europe, the Middle East and Asia has validated the ESC recommendations for predicting and preventing sudden cardiac death (SCD) in patients with ...

Hypertrophic cardiomyopathy (HCM) may sound rare, but it isn’t. This condition affects an estimated one in 250 to 500 people ...

Ventricular Arrhythmias: Which Patients Benefit Most From an ICD? —A dozen researchers at 2 U.S. universities recently examined outcomes among ischemic versus non-ischemic cardiomyopathy ...

This patient experienced sepsis-like symptoms without any identifiable infection and without dermatitis immediately following ICD implantation. What was the culprit?

Conclusions: Both ICD-9-CM and CCI coded the more major or invasive procedures reasonably well, but were not valid for less invasive or minor procedures. CCI can be used by health services and ...